Screening compound: C31H30N2O6S2 (3237-0717)

Screening compound: C<sub>31</sub>H<sub>30</sub>N<sub>2</sub>O<sub>6</sub>S<sub>2</sub> (3237-0717)
Screening compound: C<sub>31</sub>H<sub>30</sub>N<sub>2</sub>O<sub>6</sub>S<sub>2</sub> (3237-0717) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C31H30N2O6S2 (3237-0717)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3237-0717

Molecular Formula

C31H30N2O6S2 (C31 H30 N2 O6 S2)

Compound Name

2-(4-{[3-carboxy-4-(4-methylphenyl)thiophen-2-yl]carbamoyl}-3,3-dimethylbutanamido)-4-(4-methylphenyl)thiophene-3-carboxylic acid

IUPAC name

2-(4-{[3-carboxy-4-(4-methylphenyl)thiophen-2-yl]carbamoyl}-33-dimethylbutanamido)-4-(4-methylphenyl)thiophene-3-carboxylic acid

SMILES

CC(C)(CC(Nc1c(C(O)=O)c(-c2ccc(C)cc2)cs1)=O)CC(Nc1c(C(O)=O)c(-c2ccc(C)cc2)cs1)=O

InChI

InChI=1S/C31H30N2O6S2/c1-17-5-9-19(10-6-17)21-15-40-27(25(21)29(36)37)32-23(34)13-31(3,4)14-24(35)33-28-26(30(38)39)22(16-41-28)20-11-7-18(2)8-12-20/h5-12,15-16H,13-14H2,1-4H3,(H,32,34)(H,33,35)(H,36,37)(H,38,39)

InChI Key

AZPFHONVUALUSU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01925545

C31H30N2O6S2 (3237-0717) in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Others
  • Phosphatases
Mechanism of action:
  • Epigenetic
  • Epigenetic

References: we are preparing a list of scientific research reports with C31H30N2O6S2 (3237-0717) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C31H30N2O6S2 (3237-0717)?
Check Price and Availability of C31H30N2O6S2 (3237-0717), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C31H30N2O6S2 (3237-0717) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C31H30N2O6S2 (3237-0717)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C31H30N2O6S2 (3237-0717)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C31H30N2O6S2 (3237-0717) available by request